Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: Methods/New Tools, Novel Tools and Methods

Targeting Neurons with Functional Oxytocin Receptors: A Novel Set of Simple Knock-In Mouse Lines for Oxytocin Receptor Visualization and Manipulation

Yukiko U. Inoue, Hideki Miwa, Kei Hori, Ryosuke Kaneko, Yuki Morimoto, Eriko Koike, Junko Asami, Satoshi Kamijo, Mitsuhiko Yamada, Mikio Hoshino and Takayoshi Inoue
eNeuro 26 January 2022, 9 (1) ENEURO.0423-21.2022; https://doi.org/10.1523/ENEURO.0423-21.2022
Yukiko U. Inoue
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yukiko U. Inoue
Hideki Miwa
2Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kei Hori
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kei Hori
Ryosuke Kaneko
3KOKORO-Biology Group, Laboratories for Integrated Biology, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuki Morimoto
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eriko Koike
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junko Asami
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Kamijo
2Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuhiko Yamada
2Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikio Hoshino
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takayoshi Inoue
1Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The neuropeptide oxytocin (Oxt) plays important roles in modulating social behaviors. Oxt receptor (Oxtr) is abundantly expressed in the brain and its relationship to socio-behavioral controls has been extensively studied using mouse brains. Several genetic tools to visualize and/or manipulate Oxtr-expressing cells, such as fluorescent reporters and Cre recombinase drivers, have been generated by ES-cell based gene targeting or bacterial artificial chromosome (BAC) transgenesis. However, these mouse lines displayed some differences in their Oxtr expression profiles probably because of the complex context and integrity of their genomic configurations in each line. Here, we apply our sophisticated genome-editing techniques to the Oxtr locus, systematically generating a series of knock-in mouse lines, in which its endogenous transcriptional regulations are intactly preserved and evaluate their expression profiles to ensure the reliability of our new tools. We employ the epitope tagging strategy, with which C-terminally fused tags can be detected by highly specific antibodies, to successfully visualize the Oxtr protein distribution on the neural membrane with super-resolution imaging for the first time. By using T2A self-cleaving peptide sequences, we also induce proper expressions of tdTomato reporter, codon-improved Cre recombinase (iCre), and spatiotemporally inducible Cre-ERT2 in Oxtr-expressing neurons. Electrophysiological recordings from tdTomato-positive cells in the reporter mice support the validity of our tool design. Retro-orbital injections of AAV-PHP.eB vector into the Cre line further enabled visualization of recombinase activities in the appropriate brain regions. Moreover, the first-time Cre-ERT2 line drives Cre-mediated recombination in a spatiotemporally controlled manner on tamoxifen (TMX) administration. These tools thus provide an excellent resource for future functional studies in Oxt-responsive neurons and should prove of broad interest in the field.

  • Cre driver mouse
  • genome editing
  • knock-in mice
  • oxytocin
  • oxytocin receptor
  • reporter mouse

Significance Statements

Here we develop a novel series of genome-edited mouse lines to help understand the circuit mechanisms underlying oxytocin (Oxt) actions, by enabling the visualization and manipulation of Oxt receptor (Oxtr)-expressing neurons in a manner precisely reflecting their endogenous expression profiles. The epitope tagging strategy allows super-resolution imaging to decipher the 3-D distributions of Oxtr protein on neural membranes for the first time. The red fluorescent tdTomato reporter serves as a reliable visualization tool for Oxtr-expressing cells, whose expression profiles are validated using electrophysiological recordings. Both iCre and iCre-ERT2 drivers, which properly induce recombinase activities in Oxtr-expressing cells, would largely contribute to viral vector-dependent functional analyses and fate mapping studies. These tools thus offer a new option for the research communities to improve our knowledge of Oxt-Oxtr circuitry.

Introduction

The neuropeptide oxytocin (Oxt) has attracted great attention not only from researchers but also from the general public because of its profound social (Froemke and Young, 2021), pro-social (Marsh et al., 2021), anxiolytic (Neumann and Slattery, 2016), and anti-stress (Onaka and Takayanagi, 2019) behavioral effects in animals. Thanks to the advanced neuro-technologies, including optogenetics (Deisseroth, 2011; Grinevich and Neumann, 2021), chemogenetics (Grund et al., 2019; Grinevich and Neumann, 2021), and calcium imaging (Hung et al., 2017; Resendez et al., 2020; Maldonado et al., 2021), the complex neurobiology of the Oxt system has been gradually revealed over the last decade. The Oxt receptor (Oxtr), a member of the G-protein-coupled receptor (GPCR) family, processes and transfers signals into the cytoplasm to modulate downstream circuitries (Grinevich and Neumann, 2021). Although a growing number of studies have shed light on Oxt-Oxtr signaling in various brain regions such as the prefrontal cortex (PFC; Nakajima et al., 2014; Tan et al., 2019), lateral septum (Menon et al., 2018; Horiai et al., 2020), nucleus accumbens (Dölen et al., 2013; Nardou et al., 2019), hippocampus (Owen et al., 2013; Raam et al., 2017), ventral tegmental area (Hung et al., 2017), and others, each study has used different tools to visualize and manipulate Oxtr-expressing neurons.

Some studies have used an antibody (called OXTR-2) generated in a research laboratory to detect Oxtr proteins (Marlin et al., 2015; Mitre et al., 2016). Unfortunately, this antibody is not available for the public to replicate the experimental findings. In addition, because of the general difficulty in generating antibodies to lipophilic GPCRs with low epitope exposures, no anti-Oxtr antibody suitable for immunohistochemistry is commercially available. From these reasons, the Oxtr-Venus knock-in mouse line was generated (Yoshida et al., 2009) and used for receptor visualization (Dölen et al., 2013; Hung et al., 2017; Newmaster et al., 2020). However, contrary to our expectations, expressions of the Venus reporter in the brain was reported to largely decrease during development (Newmaster et al., 2020). In this reporter line, the first coding exon had been replaced with Venus sequences (Extended Data Fig. 1-1b). The resulting knock-in allele lacks its endogenous configurations of intron and 3′ untranslated region (UTR) sequences, both of which likely contain transcriptional regulatory elements essential for the spatiotemporally coordinated Oxtr expressions. This might considerably affect the Venus reporter expression profiles.

Extended Data Figure 1-1

Already-existing reporter/Cre lines for Oxtr visualization/manipulation. a, Endogenous Oxtr gene configuration is schematically depicted. Oxtr gene has two coding regions shown as solid black bars that are divided by a long intron (11.5 kb). Its 3′ UTR shown as an open bar is also relatively long (3.3 kb). b. Oxtr-Venus knock-in allele (Yoshida et al., 2009). As the 1st coding exon is replaced with Venus sequences followed by bovine growth hormone (GH) polyA signal, this allele lacks the endogenous configuration of intron and 3′ UTR sequences. c, Oxtr cDNAHA-IRES-Cre knock-in allele (Hidema et al., 2016). As is the case with Oxtr-Venus in b, the 1st coding exon is replaced with Oxtr cDNA-HA-IRES-Cre cassette. Although the C-terminally fused HA-tag is detected in uterus tissues, it cannot be detected in brain tissues. d, Oxtr Cre:GFP knock-in allele (Ryan et al., 2017). While the long intron is preserved, the exogenously integrated polyA signal is prioritized over the endogenous Oxtr’s polyA. Exogenous polyA signals might affect stabilities of mRNAs. e, Oxtr-T2A-Cre-D knock-in allele (Daigle et al., 2018). As is the case in d, the exogenously introduced polyA signal is prioritized over the endogenous Oxtr’s polyA. f, Oxtr-Cre BAC transgenic allele (Gerfen et al., 2013). Although bacterial artificial chromosome (BAC) transgenesis is undoubtedly a useful technique, a non-native genomic context via random integration might unexpectedly modify endogenous expression profiles. Download Figure 1-1, TIF file.

Cre recombinase driver mice also play pivotal roles in both conditional knock-out experiments and viral vector-dependent functional analyses. Although two Oxtr-Cre knock-in lines using internal ribosome entry site (IRES) sequences for their bicistronic expressions have been generated (Hidema et al., 2016; Ryan et al., 2017; Extended Data Fig. 1-1c,d), those expression profiles reported were relatively sparse and did not well overlap with each other, probably because of the different context and integrity of their genomic configurations. In addition, the Oxtr-T2A-Cre-D line recently became available from The Jackson Laboratory (B6.Cg-Oxtr tm1.1(Cre)Hze/J, stock #031303), generated as a part of project in Allen Institute for Brain Science (Daigle et al., 2018; Extended Data Fig. 1-1e), yet its detailed expression profile has not been described.

Endogenously, the Oxtr gene locus consists of two coding exons divided by a long intron (Extended Data Fig. 1-1a). In prairie vole and human, some single-nucleotide polymorphisms (SNPs) in this long intron have been reported to be associated with Oxtr expression densities or social behavioral phenotypes (King et al., 2016; Jurek and Neumann, 2018). The authors suggested that these SNPs might overlap with cis-regulatory elements in the intron (King et al., 2016). The 3′ UTR of the Oxtr gene has also been reported to contain nucleotide variations that are related to social behavioral phenotypes in humans (Jurek and Neumann, 2018). Considering these reports, it must be critical to design knock-in lines by maximally preserving the original transcriptional regulations, so as to precisely recapitulate endogenous Oxtr-expression profiles (Extended Data Fig.1-1 and Gerfen et al., 2013).

For proteins with no antibodies available for immunohistological detection, the epitope tagging strategy could be a promising breakthrough (Brizzard, 2008). Although the previously reported Oxtr-IRES-Cre line was designed to harbor an HA-tag at the C terminus of the receptor protein (Extended Data Fig. 1-1c), the epitope tag could not be detected in the brain tissues probably because of its relatively lower expression levels, caused by the non-native exon/intron configuration (Hidema et al., 2016). In this study, we first employed the novel PA-tag system in which human podoplanin-derived epitope tag is recognized by its highly specific monoclonal antibody (Fujii et al., 2014). Since this system has been successfully applied to many in vitro procedures, such as protein purification and visualization, we anticipated that it would also work in vivo to determine the subcellular distributions of endogenous Oxtr protein in neurons. We next used the HA-tag system, because its commercially available antibody (Cell Signaling Technology, C29F4, #3724) has been successfully adopted by in vivo genome editing technique, SLENDR, to clearly map the subcellular localization of endogenous proteins in brain tissues with low background staining (Mikuni et al., 2016).

To achieve these concepts, here we apply our refined genome-editing skills to the Oxtr locus to generate four novel knock-in mouse lines, and evaluate their expression profiles to ensure the reliability in vivo.

Materials and Methods

Animals

All animal procedures were performed in accordance with the Animal Ethics Committee’s regulations at the National Institute of Neuroscience. B6C3F1 female mice for fertilized eggs collection and ICR female mice as surrogate mothers were purchased from SLC Japan. One-cell stage zygotes were obtained by mating B6C3F1 stud males with super-ovulated females. Pronuclear injections and mouse transgenesis experiments were performed by standard protocols (Nagy et al., 2003). C57BL/6J mice for back-crossing were purchased from Charles River Japan. B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (also referred to as Ai9, stock #007909) were introduced from The Jackson Laboratory.

Preparation of CRISPR components

To insert epitope-tag, reporter, and recombinase sequences into the Oxtr locus via the CRISPR/Cas9 system, the guide RNA sequences closest to the stop codon TGA in the second exon (depicted in Fig. 1a) were selected. Two parts of the CRISPR guide RNA, crRNA and tracrRNA, were chemically synthesized (FASMAC) and recombinant Cas9 protein (EnGen Cas9 NLS S. pyogenes) was purchased from New England Biolabs. For pronuclear injections, equimolar crRNA and tracrRNA were mixed and annealed (94°C, 2 min, then at room temperature for 10 min).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A series of Oxtr knock-in mouse lines generated by CRISPR/Cas9 genome editing. a, Targeting strategy to insert a functional cassette just upstream from the translational stop codon (TGA) of mouse Oxtr gene locus is schematically outlined. Oxtr gene has two coding regions shown as solid black bars that are divided by a long intron. Its 3′ UTR shown as an open bar is also relatively long. PAM and guide sequences to recruit CRISPR components onto the Oxtr stop codon are depicted at the top. Solid gray bar indicates a knock-in cassette. Note that the endogenous Oxtr gene configuration including the long intron and 3′ UTR are intactly preserved in the resulting knock-in allele even after the genome editing. For comparison with already-existing knock-in lines, see Extended Data Figure 1-1. b, Four knock-in alleles generated in this study are schematically depicted. Epitope tag sequences (1×PA, 3×PA, or 3×HA) are fused 3′ to the Oxtr coding sequences. T2A self-cleaving peptide sequences are employed for bicistronic functional cassette expression (tdTomato, iCre, and ERT2) in Oxtr-expressing cells. Complete genomic DNA sequences and genotyping primer sequences for four knock-in lines are supplied as .dna files (Extended Data 1 DNA sequence files 1-1, 1-2, 1-3, 1-4). Detailed genotyping PCR conditions are listed in Extended Data Figure 1-2.

Extended Data 1

DNA sequence files (supplied as a zip file). Complete genomic DNA sequences and genotyping primer sequences for four knock-in lines generated in this study are supplied as .dna files that can be opened by using SnapGene software. Download Extended Data 1, ZIP file.

Extended Data Figure 1-2

Genotyping primers and PCR conditions used in this study. a, Names of four knock-in lines generated in this study are listed. b, Genotyping primer names are listed. c, Primer sequences (5′ to 3′) are listed. d, PCR enzymes used for genotyping are listed. e, PCR products’ size for knock-in alleles and wild-type allele are listed. f, PCR conditions for genotyping are listed. g, Electrophoresis conditions are listed. Download Figure 1-2, TIF file.

Generation of the Oxtr 1×PA-tdTom mouse line

To insert 1×PA-tag, T2A self-cleaving peptide, and tdTomato sequences just upstream from the stop codon (Fig. 1b), the targeting vector containing those sequences flanked by 2.9-kb homology arms on both sides was constructed by the In-Fusion cloning system (Takara Bio). The mixture of annealed crRNA/tracrRNA, Cas9 protein, and the targeting vector was injected into mouse fertilized eggs at the concentrations of 38, 50, and 25 ng/μl, and the eggs were transferred into the oviduct of surrogate mothers to raise pups.

Generation of the Oxtr 3×PA mouse line

To insert three tandem copies of PA-tag sequences just upstream from the stop codon (Fig. 1b), 3×PA-tag sequences flanked by 129- and 118-bp homology arms were artificially synthesized (Integrated DNA Technologies). To avoid unwanted excision of PA-tag sequences by the internal recombination among three copies, synonymous substitutions were introduced into each tag sequences. By using this synthesized DNA as the template, long single-stranded DNA (ssDNA) donors were prepared with the Phospho-PCR method (Guide-it Long ssDNA Production System, Takara Bio; Inoue et al., 2021). The mixture of annealed crRNA/tracrRNA, Cas9 protein, and long ssDNA donor was injected into mouse zygotes at the concentrations of 38, 50, and 25 ng/μl, and the zygotes were transferred into the oviduct of surrogate mothers to raise pups.

Generation of the Oxtr 1×PA-iCre mouse line

To insert 1×PA-tag sequences, T2A self-cleaving peptide sequences, and codon-improved Cre recombinase (iCre; Shimshek et al., 2002) sequences just upstream from the stop codon (Fig. 1b), the targeting vector containing those sequences flanked by 245- and 294-bp homology arms was constructed via the In-Fusion cloning system. By using this vector as the template, long ssDNA donors were synthesized by the Phospho-PCR method. The mixture of annealed crRNA/tracrRNA, Cas9 protein, and long ssDNA donor was injected into mouse zygotes at the concentrations of 38, 50, and 18.5 ng/μl, and the zygotes were transferred into the oviduct of surrogate mothers to raise pups.

Generation of the Oxtr 3×HA-iCreERT2 mouse line

To insert three copies of HA-tag, T2A self-cleaving peptide, iCre, and mutated ligand binding domain of the human estrogen receptor (ERT2) sequences (Indra et al., 1999) just upstream from the stop codon (Fig. 1b), the targeting vector containing those sequences flanked by 2-kb homology arms on both sides was constructed by combining artificial gene synthesis (Integrated DNA Technologies) and In-Fusion cloning system. Synonymous base substitutions were introduced into each HA-tag sequence to obviate unwanted internal recombination among them. The mixture of crRNA/tracrRNA complex, Cas9 protein, and the targeting vector was injected into mouse 1-cell embryos at the concentrations of 50, 100, and 15 ng/μl, and the embryos were transferred into the oviduct of surrogate mothers to raise pups.

Validation of the founder knock-in mice and their backcrossing

Genomic DNAs were prepared from newborns’ tail by proteinase K treatment in lysis buffer (Takara Bio). Knock-in mice were screened by PCR using Tks Gflex DNA polymerase (Takara Bio) or PrimeSTAR GXL DNA polymerase (Takara Bio). To exclude the possibilities that the donor DNAs had been randomly integrated into the genome, a subset of genotyping primers was designed external to the donor DNAs’ homology arms. For knock-in candidates, PCR products were analyzed by Sanger sequencing to confirm carrying correct insertions. Obtained founders were backcrossed with C57BL/6J to get F1 heterozygous progenies, which were again sequence-verified to harbor the designed knock-in allele. F1 heterozygous mice were then intercrossed to generate homozygous knock-in mice. For histologic, electrophysiological, and viral analyses, homozygous knock-in mice after F3 generations were used.

Antibodies and viral vectors

Primary antibodies and dilutions used were guinea pig anti-tdTomato (1:2000, Frontier Institute AB_2631185), rat anti-PA-tag (1:2000, FUJIFILM Wako Chemicals NZ-1012-25861), rabbit anti-HA-tag (1:2000, Cell Signaling Technology C29F4 3724S), goat anti-somatostatin (SST; 1:2000, Santa Cruz Biotechnology sc-7819), guinea pig anti-GFP (1:1000, Frontier Institute AB_2571575), rabbit anti-Cux1 (CDP, 1:2000, Santa Cruz Biotechnology sc-13024), and rabbit anti-Oxt (1:2000, IMMUNOSTAR 20068). Appropriate Alexa Fluor-conjugated secondary antibodies were from Thermo Fisher Scientific, Abcam, or Jackson ImmunoResearch and used at dilutions of 1:600.

AAV-PHP.eB CBh_FLEX-GFP WPRE was kindly gifted by Hirokazu Hirai [the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS), AMED].

Immunohistochemistry

Brain samples were prepared from 2- to 11-week-old male homozygous knock-in mice and immunohistochemically analyzed by standard protocols. Briefly, brains were intracardially perfused with 4% paraformaldehyde (PFA) in PBS (pH 7.4), postfixed with the same fixative for 16 h, and cryo-protected with 30% sucrose in PBS, then embedded in OCT compound (Sakura Finetek Japan) to be frozen. Brains were sliced into 40-μm coronal sections using a Leica cryostat. Sections were treated in blocking buffer (10% normal donkey serum, 0.3% Triton X-100 in PBS) for 1 h at room temperature with gentle agitation. Sections were then incubated with primary antibodies in blocking solution (3% normal donkey serum, 0.3% Triton X-100 in PBS) overnight at 4°C. After being washed with PBS, sections were treated with appropriate Alexa Fluor-conjugated secondary antibodies (Thermo Fisher Scientific, Abcam, or Jackson ImmunoResearch) and DAPI for 1 h at room temperature. After washing, sections were mounted onto glass slides with Permafluor (Thermo Fisher Scientific) or VECTASHIELD Vibrance antifade mounting medium (Vector Laboratories). Fluorescent images were obtained on a KEYENCE BZ-X710. For confocal and super-resolution imaging, an OLYMPUS SpinSR10 was used to take z-stacked images. Movies were constructed by using an OLYMPUS cellSens software.

Electrophysiological recordings from tdTomato-positive neurons in the Oxtr 1×PA-tdTom line

Coronal PFC slices (300-μm thickness) were prepared from four- to six-week-old male homozygous Oxtr 1×PA-tdTom mice, using standard procedures (Miwa et al., 2008). Slices were perfused with artificial CSF (ACSF) that was saturated with 95% O2 and 5% CO2 at 30 ± 1°C and contained 119 mM NaCl, 3.5 mM KCl, 2.5 mM CaCl2, 1.3 mM MgSO4, 1.0 mM NaH2PO4, 26.2 mM NaHCO3, and 11 mM D-glucose. Spontaneous spiking in tdTomato-expressing neurons in Layers II and V of the PFC was acquired in voltage clamp cell-attached configuration with a MultiClamp 700B patch-clamp amplifier (Molecular Devices). The pipette solution contained ACSF, and the patch was held at 0 mV. Baseline firing was acquired for 5 min, followed by bath application of 1 μM [Thr4, Gly7]-Oxt (TGOT) or 1 μM (d(CH2)51, Tyr(Me)2, Thr4, Orn8, des-Gly-NH29)-vasotocin (OTA) for 10 min. The signal was filtered at 1 kHz and digitized at 20 kHz with National Instruments DAQ board (USB-6341) and Igor Pro (Wavemetrics) with the NeuroMatic software package (Rothman and Silver, 2018). TGOT and OTA were obtained from Bachem.

Intravenous injection of AAV-PHP.eB vector to the Oxtr 1×PA-iCre line

After anesthesia with isoflurane (4%), 100 μl of viral solution (AAV-PHP.eB CBh_FLEX-GFP WPRE; 2.5 × 1012 vg/ml) was intravenously injected into the retro-orbital sinus of Oxtr 1×PA-iCre/+ mice using a 1.0-ml syringe with a 27-gauge needle. Four weeks after the injection, the mice were anesthetized with sodium pentobarbital (50 mg/kg body weight, intraperitoneal) and transcardially perfused with PBS followed by 4% PFA in 0.1 M phosphate buffer (pH 7.4). The brains were removed, postfixed in the same fixative overnight at 4°C, and immersed in 15% and 30% sucrose in PBS overnight for cryoprotection. Free-floating sections (40 μm) were cut using a sliding microtome (REM-710; Yamato Kohki Industrial Co, Ltd.) and incubated in PBS with 0.3% Triton X-100 and 1% bovine serum albumin (BSA) for 1 h at room temperature. Then, the sections were incubated for 12 h at room temperature with primary guinea pig anti-GFP antibody (1:1000; Frontier Institute) diluted in PBS with 0.3% Triton X-100, 2% BSA. The sections were washed in PBS and incubated for 2 h in Alexa Fluor 488-conjugaed species-specific secondary antibodies (Thermo Fisher Scientific) diluted 1:500 in PBS with 0.3% Triton X-100 and 2% BSA. Fluorescent images of GFP were captured using a fluorescent microscope (BZ-X710, KEYENCE).

Induction of iCre activity in the Oxtr 3×HA-iCreERT2 line by oral administration of TMX

Oxtr 3×HA-iCreERT2: : Gt(ROSA)Sor Ai9 double heterozygous males at four weeks were fed with powdered diet supplemented with tamoxifen (TMX; Sigma-Aldrich T5648) at the concentration of 2 mg/g for five consecutive days by using feeding jars (Yoshinobu et al., 2021; n = 5). For the control experiments, double heterozygous males at four weeks were fed with normal diet for five consecutive days (n = 3). After five more days, brains were sampled at five weeks and immunostained as described above. To analyze effects of chronic TMX treatment on Oxt and Oxtr expressions, five-week-old homozygous Oxtr 1×PA-tdTom males were fed with the same protocol (n = 3). Normal diet was fed to mice with the same genotype as the control (n = 3). Brains were sampled at six weeks for immunostaining.

Material availability

Four knock-in mouse lines generated in this study will be made available with a materials transfer agreement.

Results

Seamless insertions of epitope tag and functional gene cassettes into the Oxtr locus via CRISPR/Cas9 genome editing

To insert the epitope tag or reporter/recombinase sequences in-frame and 5′ to the stop codon of the Oxtr gene second exon, we selected the guide RNA sequences depicted in Figure 1a. The targeting strategies were basically the same for four knock-in lines; one or three copies of epitope tag sequences were directly fused 3′ to the Oxtr coding sequences. For bicistronic expression, we inserted T2A self-cleaving peptide sequences followed by functional gene cassettes (tdTomato reporter or Cre recombinase coding sequences). We used the T2A sequences which had been successfully used for knock-in mouse generations, to simultaneously express two separate proteins at nearly equimolar amounts from the same mRNA (Trichas et al., 2008; Tang et al., 2009).

We next employed the cloning-free CRISPR/Cas9 system in which chemically synthesized guide RNAs (crRNA and tracrRNA) were combined with recombinant Cas9 nuclease protein to induce highly efficient genome editing in mouse fertilized eggs (Aida et al., 2015; Inoue et al., 2021), and successfully generated one founder mouse for each knock-in design. We crossed these knock-in founders with C57BL/6J mice to obtain heterozygous F1 generations, which were sequence-verified to ensure that they correctly harbored the designed knock-in cassettes. We then intercrossed F1 heterozygous mice to obtain homozygous F2 generations. For histologic, electrophysiological, and viral analyses, we prepared homozygous knock-in mice after F3 generations. Complete genomic DNA sequences and genotyping primer sequences for the four knock-in lines are supplied as .dna files (Extended Data 1 DNA sequence files). Detailed genotyping PCR conditions are listed in Extended Data Figure 1-2.

The epitope tagging strategy precisely visualized the endogenous Oxtr protein expression profiles and ensured the reliability of the knock-in strategy

As depicted in Figures 1b, 2a, we first designed a dual-purpose Oxtr 1×PA-tdTom allele, in which one copy of PA-tag can monitor endogenous Oxtr protein localization and the portion of the tdTomato cassette serves as a bright fluorescent reporter. To evaluate PA-tag and tdTomato expression profiles in this line, we used homozygous male brains at two weeks [postnatal day (P)14] because Oxtr expression levels in mouse brains have been reported to peak at around two to three weeks (Newmaster et al., 2020). In the figures, we mainly presented the section equivalent to bregma −1.82 mm, as this level contains several well-known regions that have been reported to express Oxtr. Although tdTomato fluorescence could be detected without immunostaining as described later (Extended Data Fig. 3-1a,b), we double-stained the sections with anti-tdTomato and anti-PA-tag antibodies to validate their colocalization. As a result, we observed abundant tdTomato reporter signals in the cortical region (Newmaster et al., 2020), hippocampal dentate gyrus (DG) and anterior CA2 (aCA2)/CA3 (Raam et al., 2017), paraventricular thalamus (PVT; Newmaster et al., 2020; Watarai et al., 2020), central nucleus of amygdala (CeA; Yoshida et al., 2009; Mitre et al., 2016), dorsal endopiriform nucleus (DEn; Sharma et al., 2019), and posteromedial cortical amygdaloid area (PMCo; Newmaster et al., 2020; Fig. 2d), where considerable level of Oxtr expression has already been reported. Consistently, we also detected the presence of endogenous Oxtr protein by the C-terminally fused PA-tag in the same regions (Fig. 2e); however, the signal intensity was not strong enough for higher magnification, as described below. These matched results indicated that the epitope tagging and T2A-dependent bicistronic strategies we employed properly functioned as expected. We therefore applied the same design for the Oxtr 1×PA-iCre allele (Fig. 1b).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Epitope-tagging strategy precisely visualizes the endogenous Oxtr protein expression profiles and ensures the reliability of knock-in strategies. a–c, Schematic diagram of Oxtr 1×PA-tdTom allele, Oxtr 3×PA allele, and Oxtr 3×HA-iCreERT2 allele are arranged on the top. Resulting Oxtr-expressing neurons are depicted below them. To visualize endogenous Oxtr protein localization, PA-tag or HA-tag are fused to the C terminus of receptor protein and detected by anti-tag antibodies. To enhance the detection, three copies of PA-tag or HA-tag are tandemly connected. C-terminally fused PA-tag/HA-tag do not disrupt the receptor function in vivo as shown in Extended Data Figure 2-1. tdTomato reporter and iCre-ERT2 recombinase are bicistronically expressed in the cytoplasm by employing the T2A self-cleaving peptide system. d, e, Expression profiles of tdTomato reporter and 1×PA-tag in the Oxtr 1×PA-tdTom homozygous brain from two-week-old male are arranged (equivalent to bregma −1.82 mm). tdTomato expressions are observed in the areas that have been reported to express Oxtr, such as the S1BF, hippocampal DG and aCA2/CA3, PVT, CeA, DEn, and PMCo. Notably, PA-tag signals are also observed in the same regions, indicating the T2A-dependent bicistronic expression system works well. f, Expression profiles of 3×PA-tag in the Oxtr 3×PA homozygous brain from two-week-old male nicely match up with those of tdTomato in d and 1×PA-tag in e. g, Expression profiles of 3×HA-tag in the Oxtr 3×HA-iCreERT2 homozygous brain from two-week-old male well coincide with those of 1xPA-tag in e and 3×PA-tag in f. Note that independently generated three epitope-tagged lines result in the same expression profiles, ensuring the reliability of knock-in strategies. h, Magnified confocal image of the boxed area (S1BF, Layer IV) in d, e indicates tdTomato signals nicely coincide with PA-tag staining. However, this line is not suitable for higher magnification because of its unwanted background staining of PA-tag antibody. i. Enlarged confocal image of the boxed area (S1BF, Layer IV) in f shows clearer signals derived from 3×PA-tag than those from 1×PA-tag in h. j, Super-resolution image of a SST-positive PA-tagged Oxtr-expressing neuron indicates PA-tag signals are observed both on the surface of cell body and on the neurites, whereas SST is localized in the cytoplasm. 3-D movie of this interneuron is supplied as Movie 1. k, Magnified confocal image of the boxed area (S1BF, Layer IV) in g shows much clearer signals derived from 3×HA-tag than those from 1×PA-tag in h. l, Super-resolution image of an SST-positive HA-tagged Oxtr-expressing neuron indicates HA-tag signals are observed on the surface of cell body and on the neurites, reconfirming the result from 3xPA-tag knock-in line in j. 3-D movie of this interneuron is supplied as Movie 2.

Extended Data Figure 2-1

Homozygous knock-in males and females do not have any problems in their reproductive functions. a, Pups from Oxtr knock-out mothers (Oxtr –/–) has been reported to die soon after birth due to mother’s defects in breast-feeding since Oxt plays essential roles in lactation (Hidema et al., 2016). Pups’ digestive tracts are not filled with milk. b, Digestive tract of a pup from homozygous Oxtr 1×PA-tdTom mother is filled with milk, indicating homozygous mothers have no problems in lactation. c, Digestive tract of a pup from homozygous Oxtr 1×PA-iCre mother is filled with milk, indicating the peripheral Oxt signaling pathway is intact. d, Mammary glands of homozygous Oxtr 1×PA-tdTom mother are well-developed. e, A homozygous Oxtr 1×PA-iCre mother can nurse her pups by lactating. f, A pair of homozygous Oxtr 1×PA-iCre mother and father, and their homozygous progenies. Homozygous knock-in males are fertile. Download Figure 2-1, TIF file.

In the magnified confocal image of the primary somatosensory cortex barrel field (S1BF) in the Oxtr 1×PA-tdTom brain (Fig. 2h), tdTomato and PA-tag signals showed significant colocalization. However, we noticed that the use of anti-PA-tag antibody resulted in high background staining within brain tissue. To increase the signal-to-noise (S/N) ratio, we next generated the Oxtr 3×PA allele in which three tandem copies of PA-tags were simply fused to the C terminus of Oxtr (Figs. 1b, 2b). Consequently, the PA-tag signals from this 3×PA allele (Fig. 2f) perfectly coincided with those from 1×PA in the Oxtr 1×PA-tdTom allele (Fig. 2e), and its S/N ratio was improved. On comparing the magnified confocal images of the S1BF, the PA-tag signals in the Oxtr 3×PA line (Fig. 2i) were much clearer than those in the Oxtr 1×PA-tdTom allele (Fig. 2h), along with relatively lower background staining. In Figure 2i–l, we focused on SST-expressing interneurons in Layer IV, since Oxtr-expressing interneurons have been found in some brain areas to recruit local inhibitory circuits, which might be a major mode of oxytocinergic modulation in the brain (Froemke and Young, 2021), as described in Discussion.

We further designed a dual-purpose Oxtr 3×HA-iCreERT2 allele (Figs. 1b, 2c). We newly employed three copies of HA-tags for endogenous Oxtr protein visualization, because a good antibody with lower background staining in the brain tissue was commercially available. To induce spatiotemporally controlled Cre recombinase expressions in mouse brains, we fused a mutated ligand-binding domain of the human estrogen receptor (ERT2; Indra et al., 1999) with iCre recombinase. The detailed results for iCre inductions are described later. As shown in Figure 2g, the HA-tag signals from this 3×HA allele nicely coincided with those from the 1×PA and 3×PA alleles (Fig. 2e,f). On the magnified confocal image of Oxtr 3×HA-iCreERT2 brain shown in Figure 2k, we observed clear HA-tag signals, with relatively low background staining. The fact that three independently generated epitope-tagged lines resulted in exactly the same expression profiles confirms the reliability of our knock-in strategies.

Oxtr 3×PA and Oxtr 3×HA-iCreERT2 mouse lines enabled visualization of endogenous Oxtr protein at the subcellular level

We next employed spinning-disk confocal microscopy technology to observe epitope tagged Oxtr-expressing neurons at super-resolution. First, we obtained the Z-stacked 3-D image of a 3×PA-tagged neuron in the S1BF, which was identified as an SST-positive interneuron (Fig. 2j; Movie 1). We successfully detected the distribution of PA-tagged endogenous Oxtr proteins on the plasma membrane, as expected as a member of GPCRs, whereas SST was localized in the cytoplasm. This is the first evidence showing that Oxtr proteins reside both on the cell body and on nerve fibers. The super-resolution image from a 3×HA-tagged neuron further replicated the above observation, supporting the reliability of this approach (Fig. 2l; Movie 2).

Movie 1.

Super-resolution image of an SST-positive PA-tagged Oxtr-expressing neuron. PA-tag signals shown in green are observed both on the surface of cell body and on the neurites, whereas SST signals shown in magenta are localized in the cytoplasm. DAPI nuclear staining signals are shown in blue.

Movie 2.

Super-resolution image of an SST-positive HA-tagged Oxtr-expressing neuron. HA-tag signals shown in magenta are observed both on the surface of cell body and on the neurites, whereas SST signals shown in green are localized in the cytoplasm. DAPI nuclear staining signals are shown in blue.

C-terminally fused epitope tags did not disrupt the Oxtr protein function in vivo

Although our experiments have confirmed the advantage of epitope tagging in visualizing endogenous protein localization, the concern remained that C-terminally fused tags may alter Oxtr protein conformation and/or stability, affecting its functions. Since Oxt plays essential roles in lactation, pups from Oxtr knock-out mothers (Oxtr −/−) have been reported to die soon after birth, because of the mother’s defects in breastfeeding (Takayanagi et al., 2005; Hidema et al., 2016; Extended Data Fig. 2-1a). Therefore, we confirmed that all the homozygous mothers of our four knock-in lines had successfully nursed their pups. As shown in Extended Data Figure 2-1, the pups’ digestive tracts were filled with milk (Extended Data Fig. 2-1b,c) and the mother’s mammary glands were well developed (Extended Data Fig. 2-1d), indicating that the peripheral Oxt signaling pathway was intact in the homozygous females. In addition, we performed electrophysiological recordings in tdTomato-positive neurons from the homozygous Oxtr 1×PA-tdTom male, to confirm their responsiveness to agonist administration (details are shown in Fig. 3 and described later), supporting that 1×PA tagged Oxtr proteins could sufficiently mediate Oxt signals in the brain. These results indicate that fusion of one or three copies of the PA-tag or HA-tag to the C terminus of Oxtr did not affect receptor functions in vivo. It has already been reported that a much larger tdTomato protein fused C-terminally to the κ opioid receptor, which is also a member of the GPCR family, did not disrupt neuronal circuitries in the knock-in mouse brain (Chen et al., 2020). Therefore, we did not expect that the relatively smaller epitope tags we had used in the present study would affect Oxtr functions. Consistent with this assumption, all the knock-in lines we generated could be maintained by crossing homozygous males with homozygous females (Extended Data Fig. 2-1e,f), without the need for laborious genotyping procedures. This is a notable advantage of our new lines.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Functional verification of tdTomato-positive neurons in Oxtr 1×PA-tdTom mice by in vitro electrophysiological analyses. a, Schematic diagram of a mouse brain coronal section which shows placement of recording electrodes in Layer II and Layer V of the PrL. IL, infralimbic cortex. Distribution of tdTomato-positive neurons in the PrL of Oxtr 1×PA-tdTom homozygous brain are shown in Extended Data Figure 3-1. b, Representative differential interference contrast (DIC; left), fluorescent (red; middle), and merged (right) images of a Layer V neuron in the PrL from four-week-old Oxtr 1×PA-tdTom homozygous male are arranged. c, Representative cell-attached recording traces from a Layer II tdTomato-positive cell in the PrL. Left panel shows the baseline firing rate. Upon treatment of Oxtr agonist, TGOT, the firing rates are significantly increased as shown in right panel. Scale bar: 10 pA, 1 s. d, Quantification of spontaneous firing activities from Layer II tdTomato-positive cells in the PrL (n = 6 cells from 6 mice). Light red lines represent individual neurons’ responses. Red circles with line represent average response. Presence of 1 μM TGOT significantly increases the firing rate; *p < 0.05 by Wilcoxon’s test. As shown in Extended Data Figure 3-2a, this TGOT-induced increase in firing rates is inhibited by presence of Oxtr antagonist, OTA. e, Representative cell-attached recording traces from a Layer V tdTomato-positive cell in the PrL. Left panel indicates the baseline firing rate. On treatment of TGOT, the firing rates are considerably increased as shown in right panel. Scale bar: 50 pA, 1 s. d, Quantification of firing activities from Layer V tdTomato-positive cells in the PrL (n = 6 cells from 6 mice). Administration of 1 μM TGOT considerably increases the spontaneous firing rate; *p < 0.05 by Wilcoxon’s test. As shown in Extended Data Figure 3-2b, this TGOT-induced increase in firing rates is inhibited by presence of OTA.

Extended Data Figure 3-1

Characteristics of tdTomato-positive neurons in the PrL. Serial coronal sections of five-week-old homozygous Oxtr 1×PA-tdTom male brain at bregma 1.94 mm are arranged. a, Endogenous tdTomato fluorescence can be detected without immunostaining. b, Enlarged image of the boxed area in a. c, Enhanced tdTomato fluorescent signals are detected with anti-tdTomato antibody. d, Enlarged image of the boxed area in c indicates tdTomato-positive cells reside in both Layer II/III and in Layer V of the PrL. e, f, tdTomato-expressing neurons in Layer II express Cux1, one of the glutamatergic neuron markers. g, h, tdTomato-expressing neurons in Layer V express SST, one of the interneuron markers. Download Figure 3-1, TIF file.

Extended Data Figure 3-2

Blocking effects of Oxtr antagonist, OTA on TGOT-induced increase of spontaneous firing activities in tdTomato-positive neurons. a, Mean spontaneous firing activities of Layer II tdTomato-positive cells in the PrL from Oxtr 1×PA-tdTom homozygous males. Light red lines represent individual neurons’ responses. Red circles with line represent average response. Firing activities remain unchanged in the presence of 1 μm OTA (left panel, n = 6 cells from 4 mice); 1 μm TGOT application in the presence of 1 μm OTA does not increase firing activities of tdTomato-positive cells (right panel, n = 3 cells from 3 mice). ns, not significant. b, Mean spontaneous firing activities of Layer V tdTomato-positive cells in the PrL from Oxtr 1×PA-tdTom homozygous males are arranged. Firing activities remain unchanged the in presence of 1 μM OTA (left panel, n = 7 cells from 6 mice); 1 μm TGOT application in the presence of 1 μm OTA does not affect firing rates of tdTomato-positive cells (right panel, n = 5 cells from 3 mice). Download Figure 3-2, TIF file.

The tdTomato reporter in the Oxtr 1×PA-tdTom line precisely labeled Oxtr-expressing neurons

Since tdTomato has been developed as a nonaggregating, extremely bright red fluorescent protein suitable for live imaging (Shaner et al., 2004), we were able to detect tdTomato signals in our homozygous Oxtr 1×PA-tdTom brains without immunostaining (Extended Data Fig. 3-1a,b), allowing us to perform patch-clamp recordings on these cells (Fig. 3a,b). We hypothesized that tdTomato-positive neurons should correctly respond to an Oxtr agonist, TGOT, if the tdTomato expressions were faithfully regulated parallel to endogenous Oxtr expressions.

A subset of both glutamatergic and GABAergic neurons in the PFC has been reported to express Oxtr, which modulate female sociosexual behavior (Nakajima et al., 2014) and social memory (Tan et al., 2019). We first investigated the distribution of tdTomato-positive neurons in the PFC using immunohistochemistry, particularly in the prelimbic cortex (PrL) of Oxtr 1×PA-tdTom homozygous brain (Extended Data Fig. 3-1). We found that tdTomato-positive neurons mainly resided in Layers II and V of the PrL (Extended Data Fig. 3-1c,d). Consistent with a previous report (Tan et al., 2019), we identified the neurons in Layer II by Cux1 expression as glutamatergic neurons (Extended Data Fig. 3-1e,f), while the neurons in Layer V were confirmed by SST expression as GABAergic interneurons (Extended Data Fig. 3-1g,h).

To test whether these tdTomato-positive neurons in Oxtr 1×PA-tdTom mice faithfully respond to TGOT application, we used four- to six-week-old homozygous Oxtr 1×PA-tdTom males and perform in vitro electrophysiological analyses using a cell-attached patch-clamp configuration (Fig. 3a,b). We tested the neurons in Layers II and V separately (Fig. 3a), to test the possibility that they might have distinct responsiveness to Oxt ligands to modulate synaptic sites or membrane potentials. As the results, in tdTomato-positive Layer II neurons, TGOT significantly increased the spontaneous firing rate from 2.7 ± 1.0 to 7.6 ± 2.6 Hz (n = 6; p = 0.0312, Wilcoxon test; Fig. 3c,d). In tdTomato-positive Layer V neurons, TGOT also considerably increased the spontaneous firing rate from 0.99 ± 0.7 to 7.3 ± 3.3 Hz (n = 6; p = 0.0312, Wilcoxon test; Fig. 3e,f). Additionally, we confirmed that these TGOT-induced increases in spontaneous firing rates in both Layer II and V neurons were inhibited by the presence of an Oxtr antagonist, OTA (Extended Data Fig. 3-2a,b). These results clearly demonstrate that tdTomato-positive cells in Oxtr 1×PA-tdTom mice express “functional” Oxtr and appropriately respond to its ligand, even in the presence of a C-terminally fused PA-tag. Hence, tdTomato reporter signals in our Oxtr 1×PA-tdTom line are a reliable marker for Oxtr-expressing cells.

The Oxtr 1×PA-iCre line sufficiently drove recombinase activities in the Oxtr-expressing neurons

To newly generate an effective Cre driver, we employed the 2A peptide-based bicistronic expression system (Trichas et al., 2008) and codon-improved Cre recombinase (iCre) sequences (Shimshek et al., 2002). For the evaluation of Cre activities in the brain, we first crossed our Oxtr 1×PA-iCre line with the well-known Cre reporter, Ai9 (Madisen et al., 2010) to obtain double heterozygous mice. As depicted in Figure 4a, Cre-dependent stop signal excision induces tdTomato expression from the Ai9 allele. We analyzed tdTomato expression profiles in Oxtr 1×PA-iCre/+::Gt(ROSA)Sor Ai9/+ male brains at P7, P14, and P21. We observed tdTomato signals already at P7 (Fig. 4b) and found that the reporter signals became more abundant at P14 and P21 (Fig. 4c,d). Once recombination occurs, the reporter gene remains recombined thereafter, and consequently, the reporter is expressed even in the absence of ongoing recombinase expressions. In other words, a significant proportion of tdTomato expression in adult stages does not reflect real-time Cre activity but instead reflects a cumulative effect of earlier events. Therefore, we concluded that the Ai9 reporter was unsuitable for our purpose of evaluating Cre expressions in adult brains.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Oxtr 1×PA-iCre mice reliably drive recombinase activities in Oxtr-expressing cells. a, Schematics of Oxtr 1×PA-iCre allele and Gt(ROSA)Sor Ai9 allele are depicted. b–d, tdTomato expression profiles in Oxtr 1×PA-iCre/+::Gt(ROSA)Sor Ai9/+ male brains at P7, P14, and P21 are arranged (equivalent to bregma −1.82 mm). Constitutive tdTomato expressions from the Gt(ROSA)Sor locus after Cre-dependent stop signal excision gradually accumulate over time. tdTomato signals are observed already at P7 and then become more abundant at P14 and P21. e, Schematics of Oxtr 1×PA-iCre allele and AAV-PHP.eB vector harboring CBh_FLEX-GFP. GFP expression can be induced by Cre-dependent inversion. f, Expression profiles of GFP in the Oxtr 1×PA-iCre heterozygous brain (bregma −1.82 mm) from 11-week-old male to which AAV-PHP.eB vector has been retro-rbitally injected at six weeks. Other section levels are shown in Extended Data Figure 4-1. g–j, Enlarged images of the boxed areas in f are arranged. GFP expressions are observed in the areas that have been reported to express Oxtr, such as the S1BF, hippocampal DG and aCA2/CA3, PVT, CeA, and DEn, indicating this mouse line sufficiently drives Cre activities in Oxtr-expressing cells. k, Schematic diagram of Oxtr 1×PA-tdTom allele is depicted. l, tdTomato expression profiles in the Oxtr 1×PA-tdTom homozygous brain (bregma −1.82 mm) from 11-week-old male are arranged. Other section levels are shown in Extended Data Figure 4-1. m–p, Enlarged images of the boxed areas in l are arranged. These tdTomato expression profiles correspond to the GFP expressions shown in g–j induced by iCre on AAV-PHPeB administration.

Extended Data Figure 4-1

Atlas of iCre/tdTomato expression profiles. Left side, Expression profiles of GFP in Oxtr 1×PA-iCre heterozygous brain from 11-week-old male to which AAV-PHP.eB CBh_FLEX-GFP vector has been retro-orbitally injected at six weeks. Right side, tdTomato expression profiles in Oxtr 1×PA-tdTom homozygous brain from 11-week-old male. a, b, Bregma 1.78 mm. M1, primary motor cortex; S1, primary somatosensory cortex; DEn, dorsal endopiriform claustrum; IEn, intermediate endopiriform claustrum. c, d, Bregma 1.42 mm. Cg, cingulate cortex; S1, primary somatosensory cortex; AcbC, accumbens nucleus, core; AcbSh, accumbens nucleus, shell. e, f, Bregma 0.62 mm. g, h, Bregma −0.10 mm. LS, lateral septum. i, j, Bregma −0.58 mm. k, l, Bregma −2.30 mm. V2M, secondary visual cortex medial area; V1, primary visual cortex; V2L, secondary visual cortex lateral area; Au, auditory cortex. m, n, Bregma −2.92 mm. Download Figure 4-1, TIF file.

We next tried to immunostain Cre proteins in the brain tissue, using a commercially available anti-Cre recombinase antibody (clone 2D8, MAB3120, MERCK). This antibody has been reported to be successful in staining Cre proteins in transgenic lines carrying multiple copies of transgene (Mizuguchi et al., 2012). However, we could not detect Cre in the brain tissues of our iCre knock-in mouse line using this antibody.

To circumvent these issues, we employed AAV-PHP.eB vector harboring CBh-FLEX-GFP (kindly gifted by Hirokazu Hirai, Brain/MINDS project). AAV-PHP.eB has been developed to achieve efficient transport across the blood-brain barrier in adult mammalian brains for broad gene delivery (Chan et al., 2017). As depicted in Figure 4e, GFP expressions can be induced by Cre-dependent inversion. We therefore retro-orbitally injected AAV-PHP.eB vector into six-week-old heterozygous males and analyzed their brains after four weeks. As the results, we observed abundant GFP signals in the cortical region, hippocampal DG and aCA2/CA3, PVT, CeA, DEn, and so forth, where Oxtr expression has previously been reported (Fig. 4f–j, bregma −1.82 mm). Other section levels are shown in Extended Data Figure 4-1.

As we had designed the Oxtr 1×PA-tdTom and Oxtr 1×PA-iCre alleles based on the same concepts (Figs. 1b, 4e,k), their expression profiles should closely resemble each other. Predictably, we found that the tdTomato expression profiles from 11-week-old homozygous Oxtr 1×PA-tdTom male brains (Fig. 4l–p) were quite similar to those of iCre visualized by AAV-PHP.eB administration (Fig. 4f–j). Other section levels, shown in Extended Data Figure 4-1, confirm the trend. These results ensured the reliability of our new Cre driver line.

A new genetic tool, Oxtr 3×HA-iCreERT2 line, could be used to target Oxtr-expressing neurons in a spatiotemporally controlled manner

We next investigated whether the Oxtr 3×HA-iCreERT2 allele properly functioned as an inducible Cre driver. To detect Cre activity in the brain, we crossed the Oxtr 3×HA-iCreERT2 line with Ai9 to obtain double heterozygous mice. As depicted in Figure 5a, TMX binds to iCre-ERT2 expressed in the cytoplasm, resulting in iCre translocation into the nucleus to flip out the stop signal from Ai9 allele and elicit tdTomato expressions. We orally administered TMX to four-week-old males for five consecutive days by feeding them a TMX-supplemented powdered diet (Fig. 5b). For the control experiments, we fed four-week-old males with normal diet for five consecutive days. After five more days, we sampled and analyzed their brains at the level of bregma −1.82 mm. As shown in Figure 5c, the normal diet did not induce any leaky tdTomato reporter expression. Contrarily, the TMX-containing diet successfully induced iCre recombinase activity in the cortical region, hippocampal DG and aCA2/CA3, PVT, CeA, DEn, and PMCo, where Oxtr expression has previously been reported (Fig. 5d–i). In the constitutive iCre line, too many cells were labeled with tdTomato to be able to clearly distinguish each neuron (Fig. 4d). However, reporter expression was only sparsely induced in the inducible iCre line, allowing the identification of cell morphology at single-cell resolution (Fig. 5d–i). As a result, we observed two types of Oxtr-expressing neurons with different morphologies and properties in the S1BF (Fig. 5i). Consistent with the previous reports (Nakajima et al., 2014; Tan et al., 2019), some tdTomato-labeled neurons in Layer II turned out to be Cux1-positive glutamatergic neurons (Fig. 5j–l), while other tdTomato-labeled neurons in Layer IV were identified as SST-positive interneurons (Fig. 5m–o).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Cre recombinase activities can be reliably induced in Oxtr-expressing neurons on TMX administrations to the Oxtr 3×HA-iCreERT2 line. a, Schematics of Oxtr 3×HA-iCreERT2 allele and Gt(ROSA)Sor Ai9 allele are depicted. TMX binds to iCre-ERT2 expressed in the cytoplasm, resulting in iCre translocation into the nucleus to flip out stop signal from Ai9 allele and induce tdTomato expression. b, Schematic diagram of experimental protocol. Oxtr 3×HA-iCreERT2::Gt(ROSA)Sor Ai9 double heterozygous mice can freely access to TMX-supplemented diet from day 0 to day 5. At day 10, brains are sampled and immunostained. For control experiments, TMX-free normal diet is fed to same genotype mice. As shown in Extended Data Figure 5-1, 5-d TMX treatment has no effects on Oxt/Oxtr expression profiles in five-week-old males. c, TMX-free normal diet does not induce any leaky tdTomato signals in the brain from five-week-old male (bregma −1.82 mm). d, TMX-supplemented diet induces tdTomato expressions in the cortical region, hippocampal DG and aCA2/CA3, PVT, CeA, DEn, and PMCo, where Oxtr expressions has been reported. The density of the tdTomato-positive cells is much sparser than that induced by the constitutive iCre line shown in Figure 4d. e–h, Enlarged images of the boxed areas in d are arranged. i, Enlarged image of the S1BF in d. j–l, Confocal image of the boxed area in i, labeled with Cux1 immunostaining, reveals the morphology of Oxtr-expressing glutamatergic neuron in Layer II. White arrowhead in k indicates the colocalization of Cux1 and tdTomato. m–o, Confocal images of the boxed area in i, labeled with Cux1 and SST immunostaining, reveals the morphologies of Oxtr-expressing SST-positive interneurons in Layer IV. White arrows in n indicate the colocalization of SST and tdTomato.

Extended Data Figure 5-1

Five-day TMX treatment has no effect on Oxt/Oxtr expression profiles in male Oxtr 1×PA-tdTom/1×PA-tdTom mice. a, Schematic diagram of experimental protocol. Five-week-old homozygous Oxtr 1×PA-tdTom males can freely access to TMX-supplemented diet from day 0 to day 5 (n = 3). At day 10, brains are sampled for immunostaining. For control experiments, TMX-free normal diet is fed to mice with the same genotype (n = 3). b, Oxt expression profiles in respective Oxtr 1×PA-tdTom/1×PA-tdTom male brain are arranged (bregma −0.94 mm). Left column shows Oxt-expressing neurons in the PVN and SON from normal diet conditions. In right column, 5-d TMX treatment has no effect on Oxt expression profiles in these nuclei. c, tdTomato expression profiles in respective Oxtr 1×PA-tdTom/1×PA-tdTom male brain are arranged (bregma 0.62 mm). In this knock-in line, tdTomato monitors real-time Oxtr expressions. Left column shows tdTomato-expressing cells in the BNST from normal diet conditions. In right column, 5-d TMX treatment has no effect on tdTomato expressions in the BNST. d, tdTomato expression profiles in respective Oxtr 1×PA-tdTom/1×PA-tdTom male brain are arranged (bregma −1.82 mm). Left column shows tdTomato-expressing cells in the VMH, MeA, PMCo, and DEn from normal diet conditions. In right column, 5-d TMX treatment has no effect on tdTomato expressions in these brain areas. Download Figure 5-1, TIF file.

These results demonstrated that the first-time inducible-Cre driver for Oxtr-expressing neurons efficiently drives Cre-mediated recombination in a spatiotemporally controlled manner on TMX administration.

Since subcutaneous implantations of a pellet containing estrogen into gonadectomized rodents have been reported to affect Oxt/Oxtr transcript levels (Bale and Dorsa, 1995; Vanya et al., 1997; Nomura et al., 2002; Patisaul et al., 2003; Garcia et al., 2017) and radioactively labeled OTA binding to Oxtr (Young et al., 1998), chronic administrations of TMX, a selective estrogen receptor modulator, might change Oxt/Oxtr expression levels in the Oxtr 3×HA-iCreERT2 line. To analyze the effect of 5-d oral TMX treatment on Oxt/Oxtr expressions, we used homozygous Oxtr 1×PA-tdTom mice, in which real-time Oxtr expressions can be monitored as tdTomato signals, and examined Oxt-expressing neurons by immunostaining (Extended Data Fig. 5-1a). Although long-term (12 d to three months) estrogen treatments have been reported to significantly increase Oxt transcript levels in the paraventricular hypothalamic nucleus (PVN; Nomura et al., 2002; Patisaul et al., 2003) and supraoptic nucleus (SON; Garcia et al., 2017), our relatively short-term (5 d) TMX treatment did not affect Oxt expression levels in these nuclei (Extended Data Fig. 5-1b). In addition, while long-term estrogen treatments have been reported to affect Oxtr transcript levels in the bed nucleus of stria terminalis (BNST; Garcia et al., 2017), ventromedial hypothalamus (VMH; Bale and Dorsa, 1995; Vanya et al., 1997), and medial amygdala (MeA; Garcia et al., 2017), our 5-d TMX treatment had no effect on Oxtr expression profiles in these brain areas (Extended Data Fig. 5-1c,d). Furthermore, while radioactively labeled OTA binding to Oxtr has been reported to increase in the DEn and PMCo by long-term estrogen treatment (Young et al., 1998), Oxtr expression levels itself were not affected on our TMX administrations (Extended Data Fig. 5-1d). From these results, we concluded that 5-d TMX treatments have little effect on Oxt/Oxtr expression profiles in young male mice. However, we need to carefully interpret the results obtained from Oxtr 3×HA-iCreERT2 line by chronic TMX administrations because estrogens play key roles in mediating social behaviors (Laredo et al., 2014; Ervin et al., 2015) as described in Discussion.

Discussion

Genetic tools that provide access to Oxtr-expressing cells remain limited. To improve this situation, we have newly generated a series of genome-edited mouse lines that are to make a valuable contribution to the growing research on Oxt. We have created simple and seamless knock-in designs that maximally preserve the endogenous transcriptional regulation of the Oxtr gene.

The first achievement of the present study was the successful use of epitope tags to visualize Oxtr protein distributions at the subcellular level for the first time. Two strategies, the RNAscope-based in situ hybridization and the Oxtr-Venus knock-in mice, have previously been used for Oxtr visualization. However, these methods detect transcript expression, but not Oxtr protein localization per se. To overcome these limitations, we generated epitope tag knock-in mice by genome editing. We employed the PA-tag, a 12-aa epitope derived from human podoplanin, which could be detected using the rat monoclonal antibody, NZ-1 (Fujii et al., 2014). This epitope-antibody combination has been reported to show a high binding affinity of KD = 4.9 × 10−10 (M), which is much stronger than those of HA, FLAG, and other affinity tag systems, and which has been successfully used to many biological procedures in vitro (Fujii et al., 2014). In addition, we have previously reported the applicability of the PA-tag system in mouse brains and testes in in vivo studies (Arimura et al., 2020; Kimura et al., 2021). Here, we triplicated the PA-tag to improve the S/N ratio of immunostaining, by which the background staining in brain tissues were reduced, allowing us to successfully carry out super-resolution imaging of Oxtr protein. We also used the HA-tag because it has been successfully employed for SLENDR, which enabled in vivo protein labeling via genome editing in mammalian brains (Mikuni et al., 2016). Similarly, using three copies of the HA-tag enabled us to reconfirm the result from the 3×PA tag knock-in brains.

Although we have roughly demonstrated that Oxtr proteins are present not only on cell bodies but also on neurites, it remains unclear on which part of neurites (axons, dendrites, or both) they reside. To date, three types of oxytocinergic modulation on neurons have been proposed (Froemke and Young, 2021). As the first-order modulation, Oxt directly depolarizes excitatory cells that express Oxtr. In the second-order modulation, Oxt acts on inhibitory interneurons expressing Oxtr, to regulate synaptic inhibitions. Furthermore, in the third-order modulation, Oxtr is believed to reside on axon terminals, where the presynaptic Oxtr activation enhances transmitter release and indirectly impacts on other excitatory transmissions (Dölen et al., 2013; Nardou et al., 2019). However, the presence of Oxtr in axon terminals has not yet been proven. Therefore, our in vivo super-resolution imaging could serve as a significant step toward deciphering the subcellular distribution of Oxtr protein in such studies.

The second achievement of the present study was the development of an Oxtr reporter line expressing the bright red fluorescent protein, tdTomato, which is suitable for live imaging. In vitro electrophysiological analyses were successfully conducted on tdTomato-positive neurons in our reporter line. Such analyses may not have been possible in the Oxtr-Venus line (Yoshida et al., 2009), because expression levels of Venus-positive cells have been reported to largely decline after three weeks (Newmaster et al., 2020). In addition, tdTomato’s red fluorescence could be advantageous when calcium indicators such as the genetically encoded GCaMPs are used, as they mainly contain GFP and emit green fluorescence which overlaps with Venus signals.

Third, we generated both constitutive and inducible Cre drivers for Oxtr-expressing neurons. IRES elements, used in the existing two Oxtr-IRES-Cre knock-in lines, have been reported to occasionally cause lower expression of the downstream cistron because of factors such as experimental cell types or cloned gene cassettes (Ibrahimi et al., 2009). Accordingly, we employed the 2A peptide system, which allowed nearly equimolar expression of two cistrons (Trichas et al., 2008; Tang et al., 2009). As we paid much attention to maintain the endogenous Oxtr gene configuration in our knock-in allele, the design of our Oxtr-T2A-iCre is indeed different from that of Oxtr-T2A-Cre-D, available from The Jackson Laboratory (Daigle et al., 2018). While the latter inserted an exogenous bovine growth hormone poly A signal and ignored the Oxtr’s own endogenous poly A sequence (Extended Data Fig. 1-1e), our knock-in mice simply made use of the endogenous poly A signal instead (Fig. 1b). Unlike the systematically generated Cre allele as a part of a big project, our iCre knock-in allele was carefully customized for the Oxtr locus, which is a promising development for future Oxt studies. In addition, our inducible Cre line was suitably responsive to TMX administration. Although intraperitoneal injection is the most popular TMX administration protocol, it may sometimes be toxic to cause the death of test animals. Therefore, we employed an oral administration protocol (Andersson et al., 2010; Yoshinobu et al., 2021) instead, to ensure the safe and sufficient induction of Cre activity.

TMX is a potent and clinically used selective estrogen receptor modulator that blocks effects of estrogens in breast tissues but facilitates estrogen actions in others such as uterus tissues (Osborne, 1998). Thus, chronic TMX treatment has the possibility to interfere with estrogen function in multiple tissues including the brain. Estrogens are involved in social behavior at multiple levels, from the detection and integration of social information to more complex behavior such as social preference, aggression, and social learning and memory (Ervin et al., 2015). As an example, in the hippocampus, estrogens are locally synthesized and modulate memory-related synaptic plasticity by the rapid nonclassical indirect pathway via synapse-localized estrogen receptors (Mukai et al., 2010; Laredo et al., 2014). We hence need to carefully consider the potential interference by TMX to the behavioral outcomes from Oxtr manipulations in using Oxtr 3×HA-iCreERT2 mice.

Oxt and arginine vasopressin (Avp) are evolutionally related molecules that differ only in two of the 9 aa. Since their receptors also show significant structural homology to one another, the selectivity of Oxt and Avp for their own receptor is not absolute. Considerable receptor crosstalk has been reported to occur among Oxt, Avp, and their receptors (Carter, 2017; Song and Albers, 2018). While exogenously administrated Avp can act on Oxtr in higher concentration and so can do Oxt on Avp receptor 1a (Avpr1a), limited lines of evidence indicate that endogenously released Oxt and Avp can produce functionally significant responses by activating each other’s receptors (Song and Albers, 2018). Based on receptor autoradiography approach with relatively low resolution, Oxtr and Avpr1a appear to show distinct and nonoverlapping expression in the rodent brain (Dumais and Veenema, 2016). However, it remains still unknown whether the localization of Oxtr and Avpr1a is mutually exclusive at the synaptic levels, and thus the possibility of crosstalk following synaptic release of these peptides should rigorously be examined. In this context, our new genetic tools could play a part in clarifying these receptors’ distribution with much higher resolution, deepening our understanding of ligand-receptor interactions for Oxt and Avp. Generation of Avpr1a genome-edited mouse lines might further help precisely visualize its endogenous expression profiles.

Oxt is expected as a potential therapeutic for social deficits represented by autism spectrum disorders. Managing socio-emotional behavior in health and disease to increase resilience to chronic stress has become much more important, especially given the ongoing COVID-19 pandemic (Grinevich and Neumann, 2021). Although the preclinical trials of exogenous Oxt administration via intranasal delivery are currently in progress (Quintana et al., 2021), second-generation strategies to potentiate endogenous Oxt signaling should be preferred in the future (Ford and Young, 2021). Moreover, a fundamental shift from the traditional brain-wide chronic pharmacological intervention to a circuit-specific approach is now anticipated, owing to significant advances in our understanding of the neural circuit mechanisms underlying social behavior in animal models (Ford and Young, 2021). Hence, to establish dependable and effective Oxt-based therapeutic interventions, we need reliable animal models to help uncover the mechanisms underlying Oxt-Oxtr circuitry. Our new genetic tools would play a significant role in meeting this demand and we are going to make the four knock-in lines generated in this study quickly and widely available. This will eventually help deepen our knowledge for the elaborated molecular machinery and functional regions of Oxt-Oxtr actions in our own brain.

Acknowledgments

Acknowledgements: We thank all the lab members in Department of Biochemistry and Cellular Biology at NCNP for their supports.

Footnotes

  • The authors declare no competing financial interests.

  • This work was supported by Grant-in Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI) Grant Numbers 16K10004, 17H05967, 19H04922, and 20K06467 (to Y.U.I.), 18KK0442 and 19K08033 (to H.M.), and 17H05937, 19H04895, and 20H02932 (to R.K.). This work was also supported by Intramural Research Grants for Neurological and Psychiatric Disorders of National Institute of Neurology and Psychiatry (NCNP) (1-1, 30-9, 3-9; to H.M., M.Y., M.H. and T.I.) and Japan Agency for Medical Research and Development (AMED) Grant Numbers JP21wm0425005 (to M.H.) and 21ek0109490h0002 (to T.I.). Viral vectors used in this work were provided by the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from AMED under the Grant Number JP20dm0207057 and JP21dm0207111.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Aida T, Chiyo K, Usami T, Ishikubo H, Imahashi R, Wada Y, Tanaka KF, Sakuma T, Yamamoto T, Tanaka K (2015) Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol 16:87. doi:10.1186/s13059-015-0653-x pmid:25924609
    OpenUrlCrossRefPubMed
  2. ↵
    Andersson KB, Winer LH, Mørk HK, Molkentin JD, Jaisser F (2010) Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts. Transgenic Res 19:715–725. doi:10.1007/s11248-009-9342-4 pmid:19894134
    OpenUrlCrossRefPubMed
  3. ↵
    Arimura N, Okada M, Taya S, Dewa K, Tsuzuki A, Uetake H, Miyashita S, Hashizume K, Shimaoka K, Egusa S, Nishioka T, Yanagawa Y, Yamakawa K, Inoue YU, Inoue T, Kaibuchi K, Hoshino M (2020) DSCAM regulates delamination of neurons in the developing midbrain. Sci Adv 6:eaba1693.
    OpenUrlFREE Full Text
  4. ↵
    Bale TL, Dorsa DM (1995) Sex differences in and effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the ventromedial hypothalamus. Endocrinology 136:27–32. doi:10.1210/endo.136.1.7828541 pmid:7828541
    OpenUrlCrossRefPubMed
  5. ↵
    Brizzard B (2008) Epitope tagging. Biotechniques 44:693–695. doi:10.2144/000112841 pmid:18474046
    OpenUrlCrossRefPubMed
  6. ↵
    Carter CS (2017) The oxytocin–vasopressin pathway in the context of love and fear. Front Endocrinol (Lausanne) 8:356. doi:10.3389/fendo.2017.00356 pmid:29312146
    OpenUrlCrossRefPubMed
  7. ↵
    Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu W-L, Sánchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20:1172–1179. doi:10.1038/nn.4593 pmid:28671695
    OpenUrlCrossRefPubMed
  8. ↵
    Chen C, Willhouse AH, Huang P, Ko N, Wang Y, Xu B, Huang LHM, Kieffer B, Barbe MF, Liu-Chen LY (2020) Characterization of a knock-in mouse line expressing a fusion protein of k opioid receptor conjugated with tdtomato: 3-dimensional brain imaging via clarity. eNeuro 7:ENEURO.0028-20.2020–18. doi:10.1523/ENEURO.0028-20.2020
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Daigle TL, Madisen L, Hage TA, Valley MT, Knoblich U, Larsen RS, Takeno MM, Huang L, Gu H, Larsen R, Mills M, Bosma-Moody A, Siverts LA, Walker M, Graybuck LT, Yao Z, Fong O, Nguyen TN, Garren E, Lenz GH, et al. (2018) A suite of transgenic driver and reporter mouse lines with enhanced brain-cell-type targeting and functionality. Cell 174:465–480.e22. doi:10.1016/j.cell.2018.06.035 pmid:30007418
    OpenUrlCrossRefPubMed
  10. ↵
    Deisseroth K (2011) Optogenetics. Nat Methods 8:26–29. doi:10.1038/nmeth.f.324 pmid:21191368
    OpenUrlCrossRefPubMed
  11. ↵
    Dölen G, Darvishzadeh A, Huang KW, Malenka RC (2013) Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 501:179–184. doi:10.1038/nature12518 pmid:24025838
    OpenUrlCrossRefPubMed
  12. ↵
    Dumais KM, Veenema AH (2016) Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior. Front Neuroendocrinol 40:1–23. doi:10.1016/j.yfrne.2015.04.003 pmid:25951955
    OpenUrlCrossRefPubMed
  13. ↵
    Ervin KSJ, Lymer JM, Matta R, Clipperton-Allen AE, Kavaliers M, Choleris E (2015) Estrogen involvement in social behavior in rodents: rapid and long-term actions. Horm Behav 74:53–76. doi:10.1016/j.yhbeh.2015.05.023 pmid:26122289
    OpenUrlCrossRefPubMed
  14. ↵
    Ford CL, Young LJ (2021) Translational opportunities for circuit-based social neuroscience: advancing 21st century psychiatry. Curr Opin Neurobiol 68:1–8. doi:10.1016/j.conb.2020.11.007 pmid:33260106
    OpenUrlCrossRefPubMed
  15. ↵
    Froemke RC, Young LJ (2021) Oxytocin, neural plasticity, and social behavior. Annu Rev Neurosci 44:359–381. doi:10.1146/annurev-neuro-102320-102847 pmid:33823654
    OpenUrlCrossRefPubMed
  16. ↵
    Fujii Y, Kaneko M, Neyazaki M, Nogi T, Kato Y, Takagi J (2014) PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin. Protein Expr Purif 95:240–247. doi:10.1016/j.pep.2014.01.009 pmid:24480187
    OpenUrlCrossRefPubMed
  17. ↵
    Garcia AN, Bezner K, Depena C, Yin W, Gore AC (2017) The effects of long-term estradiol treatment on social behavior and gene expression in adult female rats. Horm Behav 87:145–154. doi:10.1016/j.yhbeh.2016.11.011 pmid:27871902
    OpenUrlCrossRefPubMed
  18. ↵
    Gerfen CR, Paletzki R, Heintz N (2013) GENSAT BAC Cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits. Neuron 80:1368–1383. doi:10.1016/j.neuron.2013.10.016 pmid:24360541
    OpenUrlCrossRefPubMed
  19. ↵
    Grinevich V, Neumann ID (2021) Brain oxytocin: how puzzle stones from animal studies translate into psychiatry. Mol Psychiatry 26:265–279. doi:10.1038/s41380-020-0802-9 pmid:32514104
    OpenUrlCrossRefPubMed
  20. ↵
    Grund T, Tang Y, Benusiglio D, Althammer F, Probst S, Oppenländer L, Neumann ID, Grinevich V (2019) Chemogenetic activation of oxytocin neurons: temporal dynamics, hormonal release, and behavioral consequences. Psychoneuroendocrinology 106:77–84. doi:10.1016/j.psyneuen.2019.03.019 pmid:30954921
    OpenUrlCrossRefPubMed
  21. ↵
    Hidema S, Fukuda T, Hiraoka Y, Mizukami H, Hayashi R, Otsuka A, Suzuki S, Miyazaki S, Nishimori K (2016) Generation of Oxtr cDNA(HA)-Ires-Cre mice for gene expression in an oxytocin receptor specific manner. J Cell Biochem 117:1099–1111. doi:10.1002/jcb.25393 pmid:26442453
    OpenUrlCrossRefPubMed
  22. ↵
    Horiai M, Otsuka A, Hidema S, Hiraoka Y, Hayashi R, Miyazaki S, Furuse T, Mizukami H, Teruyama R, Tamura M, Bito H, Maejima Y, Shimomura K, Nishimori K (2020) Targeting oxytocin receptor (Oxtr)-expressing neurons in the lateral septum to restore social novelty in autism spectrum disorder mouse models. Sci Rep 10:22173. doi:10.1038/s41598-020-79109-0 pmid:33335150
    OpenUrlCrossRefPubMed
  23. ↵
    Hung LW, Neuner S, Polepalli JS, Beier KT, Wright M, Walsh JJ, Lewis EM, Luo L, Deisseroth K, Dölen G, Malenka RC (2017) Gating of social reward by oxytocin in the ventral tegmental area. Science 357:1406–1411. doi:10.1126/science.aan4994 pmid:28963257
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Ibrahimi A, Vande Velde G, Reumers V, Toelen J, Thiry I, Vandeputte C, Vets S, Deroose C, Bormans G, Baekelandt V, Debyser Z, Gijsbers R (2009) Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Hum Gene Ther 20:845–860. doi:10.1089/hum.2008.188 pmid:19419274
    OpenUrlCrossRefPubMed
  25. ↵
    Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324–4327. doi:10.1093/nar/27.22.4324 pmid:10536138
    OpenUrlCrossRefPubMed
  26. ↵
    Inoue YU, Morimoto Y, Yamada M, Kaneko R, Shimaoka K, Oki S, Hotta M, Asami J, Koike E, Hori K, Hoshino M, Imayoshi I, Inoue T (2021) An optimized preparation method for long ssDNA donors to facilitate quick knock-in mouse generation. Cells 10:1076. doi:10.3390/cells10051076
    OpenUrlCrossRef
  27. ↵
    Jurek B, Neumann ID (2018) The oxytocin receptor: from intracellular signaling to behavior. Physiol Rev 98:1805–1908. doi:10.1152/physrev.00031.2017 pmid:29897293
    OpenUrlCrossRefPubMed
  28. ↵
    Kimura R, Inoue YU, Kikkawa T, Tatehana M, Morimoto Y, Inada H, Oki S, Inoue T, Osumi N (2021) Detection of REST expression in the testis using epitope‐tag knock‐in mice generated by genome editing. Dev Dyn. Advance online publication. Retrieved Sept 7, 2021. doi:10.1002/dvdy.417. doi:10.1002/dvdy.417
    OpenUrlCrossRef
  29. ↵
    King LB, Walum H, Inoue K, Eyrich NW, Young LJ (2016) Variation in the oxytocin receptor gene predicts brain region–specific expression and social attachment. Biol Psychiatry 80:160–169. doi:10.1016/j.biopsych.2015.12.008 pmid:26893121
    OpenUrlCrossRefPubMed
  30. ↵
    Laredo SA, Villalon Landeros R, Trainor BC (2014) Rapid effects of estrogens on behavior: environmental modulation and molecular mechanisms. Front Neuroendocrinol 35:447–458. doi:10.1016/j.yfrne.2014.03.005 pmid:24685383
    OpenUrlCrossRefPubMed
  31. ↵
    Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H (2010) A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133–140. doi:10.1038/nn.2467 pmid:20023653
    OpenUrlCrossRefPubMed
  32. ↵
    Maldonado PP, Nuno-Perez A, Kirchner JH, Hammock E, Gjorgjieva J, Lohmann C (2021) Oxytocin shapes spontaneous activity patterns in the developing visual cortex by activating somatostatin interneurons. Curr Biol 31:322–333.e5. doi:10.1016/j.cub.2020.10.028 pmid:33157028
    OpenUrlCrossRefPubMed
  33. ↵
    Marlin BJ, Mitre M, D’amour JA, Chao MV, Froemke RC (2015) Oxytocin enables maternal behaviour by balancing cortical inhibition. Nature 520:499–504. doi:10.1038/nature14402 pmid:25874674
    OpenUrlCrossRefPubMed
  34. ↵
    Marsh N, Marsh AA, Lee MR, Hurlemann R (2021) Oxytocin and the neurobiology of prosocial behavior. Neuroscientist 27:604–619. doi:10.1177/1073858420960111
    OpenUrlCrossRef
  35. ↵
    Menon R, Grund T, Zoicas I, Althammer F, Fiedler D, Biermeier V, Bosch OJ, Hiraoka Y, Nishimori K, Eliava M, Grinevich V, Neumann ID (2018) Oxytocin signaling in the lateral septum prevents social fear during lactation. Curr Biol 28:1066–1078.e6. doi:10.1016/j.cub.2018.02.044 pmid:29551417
    OpenUrlCrossRefPubMed
  36. ↵
    Mikuni T, Nishiyama J, Sun Y, Kamasawa N, Yasuda R (2016) High-throughput, high-resolution mapping of protein localization in mammalian brain by in vivo genome editing. Cell 165:1803–1817. doi:10.1016/j.cell.2016.04.044 pmid:27180908
    OpenUrlCrossRefPubMed
  37. ↵
    Mitre M, Marlin BJ, Schiavo JK, Morina E, Norden SE, Hackett TA, Aoki CJ, Chao MV, Froemke RC (2016) A distributed network for social cognition enriched for oxytocin receptors. J Neurosci 36:2517–2535. doi:10.1523/JNEUROSCI.2409-15.2016 pmid:26911697
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Miwa H, Fukaya M, Watabe AM, Watanabe M, Manabe T (2008) Functional contributions of synaptically localized NR2B subunits of the NMDA receptor to synaptic transmission and long-term potentiation in the adult mouse CNS. J Physiol 586:2539–2550. doi:10.1113/jphysiol.2007.147652 pmid:18372311
    OpenUrlCrossRefPubMed
  39. ↵
    Mizuguchi R, Naritsuka H, Mori K, Mao C-A, Klein WH, Yoshihara Y (2012) Tbr2 deficiency in mitral and tufted cells disrupts excitatory–inhibitory balance of neural circuitry in the mouse olfactory bulb. J Neurosci 32:8831–8844. doi:10.1523/JNEUROSCI.5746-11.2012 pmid:22745484
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Mukai H, Kimoto T, Hojo Y, Kawato S, Murakami G, Higo S, Hatanaka Y, Ogiue-Ikeda M (2010) Modulation of synaptic plasticity by brain estrogen in the hippocampus. Biochim Biophys Acta 1800:1030–1044. doi:10.1016/j.bbagen.2009.11.002 pmid:19909788
    OpenUrlCrossRefPubMed
  41. ↵
    Nagy A, Gertsenstein M, Vintersten K, Behringer R (2003) Manipulating the mouse embryo: a laboratory manual, Ed 3. New York: Cold Spring Harbor Laboratory Press.
  42. ↵
    Nakajima M, Görlich A, Heintz N (2014) Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons. Cell 159:295–305. doi:10.1016/j.cell.2014.09.020 pmid:25303526
    OpenUrlCrossRefPubMed
  43. ↵
    Nardou R, Lewis EM, Rothhaas R, Xu R, Yang A, Boyden E, Dölen G (2019) Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature 569:116–120. doi:10.1038/s41586-019-1075-9 pmid:30944474
    OpenUrlCrossRefPubMed
  44. ↵
    Neumann ID, Slattery DA (2016) Oxytocin in general anxiety and social fear: a translational approach. Biol Psychiatry 79:213–221. doi:10.1016/j.biopsych.2015.06.004 pmid:26208744
    OpenUrlCrossRefPubMed
  45. ↵
    Newmaster KT, Nolan ZT, Chon U, Vanselow DJ, Weit AR, Tabbaa M, Hidema S, Nishimori K, Hammock EAD, Kim Y (2020) Quantitative cellular-resolution map of the oxytocin receptor in postnatally developing mouse brains. Nat Commun 11:1885. doi:10.1038/s41467-020-15659-1
    OpenUrlCrossRef
  46. ↵
    Nomura M, McKenna E, Korach KS, Pfaff DW, Ogawa S (2002) Estrogen receptor-β regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice. Brain Res Mol 109:84–94. doi:10.1016/s0169-328x(02)00525-9 pmid:12531518
    OpenUrlCrossRefPubMed
  47. ↵
    Onaka T, Takayanagi Y (2019) Role of oxytocin in the control of stress and food intake. J Neuroendocrinol 31:e12700. doi:10.1111/jne.12700 pmid:30786104
    OpenUrlCrossRefPubMed
  48. ↵
    Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609–1618. doi:10.1056/NEJM199811263392207 pmid:9828250
    OpenUrlCrossRefPubMed
  49. ↵
    Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW (2013) Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 500:458–462. doi:10.1038/nature12330 pmid:23913275
    OpenUrlCrossRefPubMed
  50. ↵
    Patisaul HB, Scordalakes EM, Young LJ, Rissman EF (2003) Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor β in the female mouse hypothalamus. J Neuroendocrinol 15:787–793. doi:10.1046/j.1365-2826.2003.01061.x pmid:12834440
    OpenUrlCrossRefPubMed
  51. ↵
    Quintana DS, Lischke A, Grace S, Scheele D, Ma Y, Becker B (2021) Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research. Mol Psychiatry 26:80–91. doi:10.1038/s41380-020-00864-7 pmid:32807845
    OpenUrlCrossRefPubMed
  52. ↵
    Raam T, McAvoy KM, Besnard A, Veenema A, Sahay A (2017) Hippocampal oxytocin receptors are necessary for discrimination of social stimuli. Nat Commun 8:2001. doi:10.1038/s41467-017-02173-0
    OpenUrlCrossRefPubMed
  53. ↵
    Resendez SL, Namboodiri VMK, Otis JM, Eckman LEH, Rodriguez-Romaguera J, Ung RL, Basiri ML, Kosyk O, Rossi MA, Dichter GS, Stuber GD (2020) Social stimuli induce activation of oxytocin neurons within the paraventricular nucleus of the hypothalamus to promote social behavior in male mice. J Neurosci 40:2282–2295. doi:10.1523/JNEUROSCI.1515-18.2020 pmid:32024781
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Rothman JS, Silver RA (2018) Neuromatic: an integrated open-source software toolkit for acquisition, analysis and simulation of electrophysiological data. Front Neuroinform 12:1–21.
    OpenUrl
  55. ↵
    Ryan PJ, Ross SI, Campos CA, Derkach VA, Palmiter RD (2017) Oxytocin-receptor-expressing neurons in the parabrachial nucleus regulate fluid intake. Nat Neurosci 20:1722–1733. doi:10.1038/s41593-017-0014-z pmid:29184212
    OpenUrlCrossRefPubMed
  56. ↵
    Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567–1572. doi:10.1038/nbt1037 pmid:15558047
    OpenUrlCrossRefPubMed
  57. ↵
    Sharma K, LeBlanc R, Haque M, Nishimori K, Reid MM, Teruyama R (2019) Sexually dimorphic oxytocin receptor-expressing neurons in the preoptic area of the mouse brain. PLoS One 14:e0219784. doi:10.1371/journal.pone.0219784 pmid:31295328
    OpenUrlCrossRefPubMed
  58. ↵
    Shimshek DR, Kim J, Hübner MR, Spergel DJ, Buchholz F, Casanova E, Stewart AF, Seeburg PH, Sprengel R (2002) Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis 32:19–26. doi:10.1002/gene.10023 pmid:11835670
    OpenUrlCrossRefPubMed
  59. ↵
    Song Z, Albers HE (2018) Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery. Front Neuroendocrinol 51:14–24. doi:10.1016/j.yfrne.2017.10.004 pmid:29054552
    OpenUrlCrossRefPubMed
  60. ↵
    Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K (2005) Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Proc Natl Acad Sci USA 102:16096–16101. doi:10.1073/pnas.0505312102 pmid:16249339
    OpenUrlAbstract/FREE Full Text
  61. ↵
    Tan Y, Singhal SM, Harden SW, Cahill KM, Nguyen DTM, Colon-Perez LM, Sahagian TJ, Thinschmidt JS, De Kloet AD, Febo M, Frazier CJ, Krause EG (2019) Oxytocin receptors are expressed by glutamatergic prefrontal cortical neurons that selectively modulate social recognition. J Neurosci 39:3249–3263. doi:10.1523/JNEUROSCI.2944-18.2019 pmid:30804095
    OpenUrlAbstract/FREE Full Text
  62. ↵
    Tang W, Ehrlich I, Wolff SBE, Michalski A-M, Wölfl S, Hasan MT, Lüthi A, Sprengel R (2009) Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits. J Neurosci 29:8621–8629. doi:10.1523/JNEUROSCI.0359-09.2009 pmid:19587267
    OpenUrlFREE Full Text
  63. ↵
    Trichas G, Begbie J, Srinivas S (2008) Use of the viral 2A peptide for bicistronic expression in transgenic mice. BMC Biol 6:40. doi:10.1186/1741-7007-6-40 pmid:18793381
    OpenUrlCrossRefPubMed
  64. ↵
    Vanya Q-J, Jenab S, Ogawa S, Adan RA, Burbach JP, Pfaff DW (1997) Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat. Neuroendocrinology 65:9–17. doi:10.1159/000127160 pmid:9032770
    OpenUrlCrossRefPubMed
  65. ↵
    Watarai A, Tsutaki S, Nishimori K, Okuyama T, Mogi K, Kikusui T (2020) The blockade of oxytocin receptors in the paraventricular thalamus reduces maternal crouching behavior over pups in lactating mice. Neurosci Lett 720:134761. doi:10.1016/j.neulet.2020.134761 pmid:31952987
    OpenUrlCrossRefPubMed
  66. ↵
    Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K (2009) Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 29:2259–2271. doi:10.1523/JNEUROSCI.5593-08.2009 pmid:19228979
    OpenUrlAbstract/FREE Full Text
  67. ↵
    Yoshinobu K, Araki M, Morita A, Araki M, Kokuba S, Nakagata N, Araki K (2021) Tamoxifen feeding method is suitable for efficient conditional knockout. Exp Anim 70:91–100. doi:10.1538/expanim.19-0138 pmid:33055491
    OpenUrlCrossRefPubMed
  68. ↵
    Young LJ, Wang Z, Donaldson R, Rissman EF (1998) Estrogen receptor α is essential for induction of oxytocin receptor by estrogen. Neuroreport 9:933–936. doi:10.1097/00001756-199803300-00031 pmid:9579693
    OpenUrlCrossRefPubMed

Synthesis

Reviewing Editor: Karyn Frick, University of Wisconsin-Milwaukee

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Heather Caldwell, Françoise Muscatelli.

This article reports the creation of 4 novel knock-in mouse lines at the Oxtr-locus, allowing a normal expression of the Oxtr transcript and protein, which is important to maintain since the Oxtr-knock out hetreozygotes present an abnormal phenotype. The reviewers thought that the mouse lines could be reliable and powerful tools that would be very useful to the scientific community. The development of these lines of mice could aid researchers in various aspects of their work, including identifying where oxytocin receptors are located on neurons, the types of neurons on which oxytocin receptors are expressed, and will allow for oxytocin receptor-expressing cells to be identified for electrophysiological work. It was felt that these tools are very likely to advance the field if made available to researchers by opening up a new set of tools for researchers interested in the oxytocin receptor to use and by increasing reproducibility and reliability within the field.

With respect to the manuscript itself, the reviewers found this to be a very nice technical paper. They felt that the manuscript was well-written. The construction of all lines was thought to be well described and the characterization of the expression of the different reporters and Oxtr expression at the cell membrane was considered well done and convincing. That said, the reviewers expressed a few concerns that should be addressed in a revised manuscript.

1. Some of the background information that informed some of the specific choices made by the authors with respect to the lines created is a bit thin in some areas. For instance, while the PA epitope tagging is explained a bit, the HA-tag is only mentioned in passing, and it was not clear why the authors use PA instead of HA. While it is understood that the authors are essentially sharing their “story” about what worked well and what had to be altered experimentally, better clarity in the introduction would help support the presentation of ideas that come up later in the text and decrease confusion.

2. The authors state that these lines will inform our understanding of “Oxt-responsive” neurons, this is also indicated in the title of the article. However, the development of these mouse lines will inform research beyond understanding Oxt-Oxtr signaling since vasopressin can also signal through the Oxtr. Thus, the authors may want to consider broadening their statements about the potential impact of the work.

3. There were some problems with English grammar, and thorough proofreading with a focus on grammar should be done to increase readability.

Back to top

In this issue

eneuro: 9 (1)
eNeuro
Vol. 9, Issue 1
January/February 2022
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Targeting Neurons with Functional Oxytocin Receptors: A Novel Set of Simple Knock-In Mouse Lines for Oxytocin Receptor Visualization and Manipulation
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Targeting Neurons with Functional Oxytocin Receptors: A Novel Set of Simple Knock-In Mouse Lines for Oxytocin Receptor Visualization and Manipulation
Yukiko U. Inoue, Hideki Miwa, Kei Hori, Ryosuke Kaneko, Yuki Morimoto, Eriko Koike, Junko Asami, Satoshi Kamijo, Mitsuhiko Yamada, Mikio Hoshino, Takayoshi Inoue
eNeuro 26 January 2022, 9 (1) ENEURO.0423-21.2022; DOI: 10.1523/ENEURO.0423-21.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Targeting Neurons with Functional Oxytocin Receptors: A Novel Set of Simple Knock-In Mouse Lines for Oxytocin Receptor Visualization and Manipulation
Yukiko U. Inoue, Hideki Miwa, Kei Hori, Ryosuke Kaneko, Yuki Morimoto, Eriko Koike, Junko Asami, Satoshi Kamijo, Mitsuhiko Yamada, Mikio Hoshino, Takayoshi Inoue
eNeuro 26 January 2022, 9 (1) ENEURO.0423-21.2022; DOI: 10.1523/ENEURO.0423-21.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statements
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Cre driver mouse
  • genome editing
  • knock-in mice
  • oxytocin
  • oxytocin receptor
  • reporter mouse

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: Methods/New Tools

  • Adapt-A-Maze: An Open Source Adaptable and Automated Rodent Behavior Maze System
  • Generation of iPSC lines with tagged α-synuclein for visualization of endogenous protein in human cellular models of neurodegenerative disorders
  • Chronic Intraventricular Cannulation for the Study of Glymphatic Transport
Show more Research Article: Methods/New Tools

Novel Tools and Methods

  • Adapt-A-Maze: An Open Source Adaptable and Automated Rodent Behavior Maze System
  • Chronic Intraventricular Cannulation for the Study of Glymphatic Transport
  • Generation of iPSC lines with tagged α-synuclein for visualization of endogenous protein in human cellular models of neurodegenerative disorders
Show more Novel Tools and Methods

Subjects

  • Novel Tools and Methods
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.